vaccine

Non passa mai di moda: il morbillo

Campodipietro G, de Palo B, Andreozzi L, Dondi A, Lanari M.

2025/5 — pag. 323-326 — DOI

The paper describes the case of a 10-year-old girl with persistent fever for approximately one week, poor general condition, skin rash, bilateral non-exudative conjunctivitis, cough, rhinitis, abdominal pain and vomiting. The patient was finally diag...

Vaccini Covid-19: disponibilità ed efficacia

Davanzo R

2021/3 — pag. 181-185 — DOI

The Covid-19 vaccination campaign represents a challenge for the health system. Eight Covid-19 vaccines belonging to 4 different categories of technology are currently available. More than the specific type of selected vaccine, major influencing fact...

Gli interventi di salute nelle collettività: un modello di comportamento integrato nella gestione di un focolaio di epatite A in una scuola

Ghini T, Daniloiu AG, Sintoni F, Bertozzi N, Brunelli A

2021/1 — pag. 22-24 — DOI

The paper describes 2 cases of hepatitis A related to each other and occurring in the context of the same school. We illustrate the sequence of actions taken towards individuals and the community in order to contain the spread of the epidemic outbrea...

Un altro caso di pertosse: l’importanza della prevenzione in gravidanza

G. Nuzzi, G. Costagliola, E. Bellino, M.C. De Muto, M. Botti, A. Orsini, D. Peroni, G.I. Baroncelli

2019/7 — pag. 144-146

Pertussis is a highly infectious vaccine-preventable cough illness that is still a significant cause of morbidity and mortality around the world. It is caused by Bordetella pertussis, a Gram-negative aerobic coccobacillus that is spread by respir...

Vaccinazioni e gravidanza: più certezze che dubbi

R. Cavallo, A. Ventura

2018/3 — pag. 178-183

The approach to vaccines during pregnancy is frequently based on faiths more than on facts. This state-of-the-art paper discusses the scientific evidences that should be considered in deciding whether to prescribe or discourage vaccinations in preg...

Un caso di cerebellite acuta di verosimile natura post-vaccinica

M. Daverio, C. Moretti

2013/1 — pag. 53-56

Vaccinazione anti-rotavirus:intervento lodevole ma… fa risparmiare il sistema sanitario nazionale?L’esperienza del Brasile

C. Centenari, G. Maggiore, R.Q. Gurgel, L.E. Cuevas

2011/3 — pag. 191-192

The present “budget impact” study assessed the family and health system costs due to diarrhoea in children < 2 years old, before/after the introduction of a rotavirus vaccine in Brazil in 2006. This kind of evaluations plays a crucial role in the ...

Il Pap-test? Certamente! La vaccinazione anti-HPV? Sì, eventualmente

M. Bonati

2008/4 — pag. 251-253

Human papillomavirus (HPV) is associated with an increased risk of cervical cancer. However, only a few infected women develop cervical carcinoma. Combined cytology and HPV DNA screening are effective preventive interventions. Today, two vaccines a...

Il vaccino contro il papillomavirus umano: efficacia dichiarata ed efficacia dimostrata

S. Di Mario, M. Bergamini, D. Spettoli, V. Basevi, N. Magrini

2007/9 — pag. 562-571

The recent introduction in the European market of the tetravalent vaccine against Human Papillomavirus raises some concerns on the opportunity to start a national vaccination campaign. In this article an analysis of the currently available evidence, ...

Herpes zoster breakthrough

F. Napolano

2006/1 — pag. 53-54

The latent varicella vaccine virus is a rare cause of herpes zoster in childhood. We report the case of a healthy 2 years old boy who developed an herpes zoster infection 6 months after vaccination, localised in one chest dermatoma. Varicella zoster ...

Reazioni avverse lievi e gravi (rare) ai vaccini: una revisione

G. Bartolozzi

1997/10 — pag. 643-647

Adverse reactions to vaccine vary from trivial to severe. Mild reactions include systemic symptoms (fever after DTP vaccine or rash after live measles vaccine) or local flogosis after DTP. Sterile abscesses may occur after immunization with a va...